Arcturus Therapeutics Holdings Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 610K | 3.1M | 17.2M | 24.5M | 29.4M | 21.0M | 38.8M | 46.0M |
| Cost of Goods Sold | 658K | 0 | 3.3M | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -48K | 3.1M | 13.8M | 24.5M | 29.4M | 21.0M | 38.8M | 46.0M |
| R&D Expenses | 20.9M | 24.5M | 23.3M | 29.6M | 34.9M | 43.8M | 39.1M | 58.7M |
| Operating Expenses | 29.7M | 34.4M | 30.3M | 36.1M | 46.2M | 54.4M | 49.6M | 67.1M |
| Operating Income | -29.8M | -31.3M | -16.5M | -11.6M | -16.8M | -33.4M | -10.7M | -21.1M |
| Other Income / Gains | 2.8M | 2.2M | 3.1M | 2.4M | 2.8M | 3.4M | 3.6M | 3.8M |
| Net Income | -27.0M | -29.1M | -13.4M | -9.2M | -14.1M | -30.0M | -6.9M | -17.2M |
| EPS (Diluted) | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 | -0.64 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -0.079 | 1.00 | 0.805 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 9.5M | 14.0M | 10.4M | 10.3M | 11.3M | 12.4M | 13.3M | 12.3M |
| Selling And Marketing Expenses | -658K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 8.8M | 14.0M | 10.4M | 10.3M | 11.3M | 12.4M | 13.3M | 12.3M |
| Other Expenses | 0 | -4.1M | -3.3M | -3.8M | 0 | -1.8M | -2.9M | -3.9M |
| Cost And Expenses | 30.4M | 34.4M | 33.7M | 36.1M | 46.2M | 54.4M | 49.6M | 67.1M |
| Interest Income | 1.9M | 1.5M | 3.2M | 2.6M | 2.8M | 3.2M | 7.6M | 4.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 658K | 682K | 763K | 779K | 801K | 819K | 912K | 909K |
| Ebitda | -26.3M | -20.1M | -12.7M | -8.4M | -13.3M | -29.2M | -6.2M | -16.5M |
| Ebitdaratio | -43.125 | -6.537 | -0.74 | -0.343 | -0.452 | -1.39 | -0.16 | -0.358 |
| Operating Income Ratio | -48.82 | -10.161 | -0.963 | -0.474 | -0.573 | -1.59 | -0.277 | -0.46 |
| Income Before Tax | -27.0M | -29.1M | -13.4M | -9.2M | -14.1M | -30.0M | -7.1M | -17.4M |
| Income Before Tax Ratio | -44.203 | -9.439 | -0.784 | -0.374 | -0.479 | -1.429 | -0.183 | -0.378 |
| Income Tax Expense | 0 | -4K | 0 | 4K | 0 | -4K | -217K | -150K |
| Net Income Ratio | -44.203 | -9.438 | -0.784 | -0.375 | -0.479 | -1.429 | -0.178 | -0.374 |
| Epsdiluted | -0.95 | -1.05 | -0.49 | -0.34 | -0.52 | -1.11 | -0.26 | -0.64 |
| Weighted Average Shs Out | 28.4M | 27.4M | 27.2M | 27.1M | 27.1M | 27.0M | 27.1M | 27.0M |
| Weighted Average Shs Out Dil | 28.4M | 27.4M | 27.2M | 27.1M | 27.1M | 27.0M | 27.1M | 27.0M |